Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 104.23B P/E 39.91 EPS this Y 13.20% Ern Qtrly Grth 11.80%
Income 3.45B Forward P/E 24.47 EPS next Y 12.40% 50D Avg Chg -5.00%
Sales 21.39B PEG 2.64 EPS past 5Y 9.93% 200D Avg Chg 3.00%
Dividend 1.00% Price/Book 6.17 EPS next 5Y 11.29% 52W High Chg -11.00%
Recommedations 2.00 Quick Ratio 0.81 Shares Outstanding 381.08M 52W Low Chg 37.00%
Insider Own 5.38% ROA 7.24% Shares Float 341.91M Beta 0.92
Inst Own 79.30% ROE 18.58% Shares Shorted/Prior 4.27M/3.75M Price 274.57
Gross Margin 64.01% Profit Margin 16.12% Avg. Volume 1,291,643 Target Price 378.21
Oper. Margin 21.19% Earnings Date Oct 31 Volume 1,914,364 Change -1.68%
About Stryker Corporation

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

Stryker Corporation News
12/19/24 Stryker price target raised to $409 from $380 at Truist
12/18/24 HAE or SYK: Which Is the Better Value Stock Right Now?
12/17/24 Top Stock Reports for Tesla, Broadcom & Bank of America
12/17/24 Reasons to Invest in Stryker Corp. (SYK)
12/17/24 Here's Why You Should Retain Stryker Stock in Your Portfolio for Now
12/15/24 Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
12/13/24 Stryker (NYSE:SYK) Is Increasing Its Dividend To $0.84
12/12/24 Needham names Stryker top pick for 2025 on new products, margin gains
12/12/24 3 Stocks to Keep an Eye on After Dividend Hike Announcement
12/10/24 Stryker declares an $0.84 per share quarterly dividend
12/06/24 Phibro (PAHC) Down 2.5% Since Last Earnings Report: Can It Rebound?
12/05/24 Stryker Gains 30.2% Year to Date: What's Driving the Stock?
12/04/24 The Zacks Analyst Blog Highlights Amazon.com, Stryker, Lam Research and ImmuCell
12/03/24 Top Research Reports for Amazon, Stryker & Lam Research
12/03/24 Stryker Corporation (SYK): A Bull Case Theory
12/03/24 Here’s Mar Vista Strategic Growth Strategy’s Investment Thesis for Stryker Corporation (SYK)
12/02/24 Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
11/27/24 PBH or SYK: Which Is the Better Value Stock Right Now?
11/27/24 Do Options Traders Know Something About Stryker (SYK) Stock We Don't?
11/20/24 Stryker Stock May Gain From Oculan Lighting Platform's Launch
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Golston Allan C. Director Director Feb 02 Sell 341 3,273 1,116,093 14,242 02/06/24
Golston Allan C. Director Director Feb 02 Option 96.64 4,570 441,645 18,812 02/06/24
STRYKER RONDA E Director Director Feb 02 Option 81.14 4,355 353,365 7,642 02/06/24
Becker Yin C VP, Chief Corp Affai.. VP, Chief Corp Affairs Officer Nov 28 Option 81.14 8,875 720,118 30,806 11/28/23
Berry William E Jr VP, Chief Accounting.. VP, Chief Accounting Officer Nov 28 Sell 292.2805 573 167,477 2,909 11/28/23
Boehnlein Glenn S VP, Chief Financial.. VP, Chief Financial Officer Nov 27 Option 81.14 11,955 970,029 16,570 11/28/23
Stiles Spencer S Group President Group President Nov 17 Option 81.14 11,090 899,843 53,732 11/21/23
Datar Srikant M. Director Director Nov 14 Sell 289 1,750 505,750 4,316 11/16/23
Datar Srikant M. Director Director Jun 01 Sell 278.50 500 139,250 5,467 06/05/23
Datar Srikant M. Director Director May 18 Sell 286 1,000 286,000 5,967 05/19/23
Golston Allan C. Director Director Feb 28 Sell 263.27 5,459 1,437,191 13,537 03/01/23
Golston Allan C. Director Director Feb 28 Option 87.1 8,150 709,865 21,687 03/01/23
STRYKER RONDA E Director Director Feb 06 Sell 273.97 520,000 142,464,400 4,730,754 02/08/23
STRYKER RONDA E Director Director Feb 02 Option 64.01 5,520 353,335 7,054 02/06/23
Pierce James Andrew Group President Group President Feb 02 Sell 277.88 400 111,152 46,676 02/06/23
Pierce James Andrew Group President Group President Feb 02 Option 64.01 12,500 800,125 54,204 02/06/23
Fletcher Robert S VP, Chief Legal Offi.. VP, Chief Legal Officer Feb 03 Sell 283.5368 3,000 850,610 6,636 02/06/23
Boehnlein Glenn S VP, Chief Financial.. VP, Chief Financial Officer Feb 02 Sell 278.85 24,425 6,810,911 2,428 02/06/23
Berry William E Jr VP, Chief Accounting.. VP, Chief Accounting Officer Feb 02 Sell 279.85 4,058 1,135,631 2,886 02/06/23
Berry William E Jr VP, Chief Accounting.. VP, Chief Accounting Officer Feb 02 Option 93.06 7,415 690,040 11,056 02/06/23
Becker Yin C VP, Chief Corp Affai.. VP, Chief Corp Affairs Officer Feb 02 Option 64.01 4,885 312,689 24,096 02/06/23
Boehnlein Glenn S VP, Chief Financial.. VP, Chief Financial Officer Jan 11 Option 64.01 14,515 929,105 35,286 01/12/23
Fink M Kathryn VP, Chief HR Officer VP, Chief HR Officer Jan 09 Sell 259.37 10,107 2,621,453 9,264 01/11/23
Fink M Kathryn VP, Chief HR Officer VP, Chief HR Officer Jan 09 Option 94.85 6,571 623,259 15,835 01/11/23
Datar Srikant M. Director Director Nov 07 Sell 212.3573 300 63,707 4,861 11/08/22
Datar Srikant M. Director Director Nov 02 Sell 216.71 600 130,026 5,161 11/04/22
Datar Srikant M. Director Director Mar 30 Option 64.01 3,520 225,315 5,053 03/31/22
Boehnlein Glenn S VP, Chief Financial.. VP, Chief Financial Officer Dec 10 Sell 259.81 2,778 721,752 13,105 12/14/21
Becker Yin C VP, Chief Corp Affai.. VP, Chief Corp Affairs Officer Nov 26 Option 53.6 8,630 462,568 20,382 11/30/21
Datar Srikant M. Director Director Sep 13 Option 64.01 2,000 128,020 2,991 09/13/21
Lobo Kevin Chair and CEO Chair and CEO May 06 Option 55.66 107,795 5,999,870 171,773 05/06/21
Lobo Kevin Chair and CEO Chair and CEO May 06 Sell 255.79 107,795 27,572,883 63,978 05/06/21
Berry William E Jr VP, Corporate Contro.. VP, Corporate Controller Apr 14 Option 72.58 9,100 660,478 9,601 04/14/21
Datar Srikant M. Director Director Sep 18 Option 53.6 3,000 160,800 19,091 09/18/20